Main Session
Sep 28
PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer

2509 - Evaluating [<sup>18</sup>F]Fluorodeoxyglucose (FDG) Uptake as a Prognostic Metric in Stage IV Lung Cancer Patients Being Treated with Pharmacological Ascorbate and Chemotherapy

04:45pm - 06:00pm PT
Hall F

Presenter(s)

Ashley Way, MD - University of Iowa Hospitals & Clinics, Iowa City, IA